The results showed that high PDGFA (Affymetrix ID: 205463_s_at) expression correlated with decreased overall survival (OS) but did not impact progression-free survival (PFS) in ovarian cancer patients (HR 1.54 (95% CI 1.19–1.99); p < 0.001 for OS; HR 0.87 (95% CI 0.68–1.11); p < 0.25 for PFS). This evidence concerns the gene PDGFA and ovarian carcinoma.